Loading clinical trials...
Loading clinical trials...
Background/Rationale: Neurofibromatosis type 1 (NF1) affects about 1 in every 3000 people worldwide. Globally, 30\~50% NF1 patients will develop plexiform neurofibromas (PNs), which grow rapidly in ea...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
NCT04750928 · Neurofibromatosis 1
NCT05735717 · Hematologic Malignancy, Acute Leukemia, and more
NCT05361811 · Neurofibromatosis 1, Noonan Syndrome, and more
NCT04395495 · RAS Mutation, Neurofibromatosis 1, and more
NCT06262113 · Neurofibromatosis 1
Xuanwu Hospital, Capital Medical University
Beijing, Beijing Municipality
The First Affiliated Hospital of Guangxi Medical University
Nanning, Guangxi
The First Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions